{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:21:32Z","timestamp":1772245292736,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["836031008"],"award-info":[{"award-number":["836031008"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["160KK26"],"award-info":[{"award-number":["160KK26"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00467-018-4118-9","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T04:51:18Z","timestamp":1540529478000},"page":"631-639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Glyco-iELISA: a highly sensitive and unambiguous serological method to diagnose STEC-HUS caused by serotype O157"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0019-109X","authenticated-orcid":false,"given":"Kioa L.","family":"Wijnsma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan T.","family":"Veissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila A. M.","family":"van Bommel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik","family":"Heuver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena B.","family":"Volokhina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego J.","family":"Comerci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan E.","family":"Ugalde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole C. A. J.","family":"van de Kar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lambertus P. W. J.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"key":"4118_CR1","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1128\/JCM.00115-15","volume":"53","author":"X Qin","year":"2015","unstructured":"Qin X, Klein EJ, Galanakis E, Thomas AA, Stapp JR, Rich S, Buccat AM, Tarr PI (2015) Real-time PCR assay for detection and differentiation of Shiga toxin-producing Escherichia coli from clinical samples. J Clin Microbiol 53:2148\u20132153. \n                    https:\/\/doi.org\/10.1128\/JCM.00115-15","journal-title":"J Clin Microbiol"},{"key":"4118_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/INF.0b013e31816a062f","volume":"27","author":"E Espie","year":"2008","unstructured":"Espie E, Grimont F, Mariani-Kurkdjian P, Bouvet P, Haeghebaert S, Filliol I, Loirat C, Decludt B, Minh NN, Vaillant V, de Valk H (2008) Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Pediatr Infect Dis J 27:595\u2013601. \n                    https:\/\/doi.org\/10.1097\/INF.0b013e31816a062f","journal-title":"Pediatr Infect Dis J"},{"key":"4118_CR3","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1128\/JCM.01231-14","volume":"52","author":"EI Schindler","year":"2014","unstructured":"Schindler EI, Sellenriek P, Storch GA, Tarr PI, Burnham CA (2014) Shiga toxin-producing Escherichia coli: a single-center, 11-year pediatric experience. J Clin Microbiol 52:3647\u20133653. \n                    https:\/\/doi.org\/10.1128\/JCM.01231-14","journal-title":"J Clin Microbiol"},{"key":"4118_CR4","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1128\/JCM.03590-14","volume":"53","author":"RF Boer de","year":"2015","unstructured":"de Boer RF, Ferdous M, Ott A, Scheper HR, Wisselink GJ, Heck ME, Rossen JW, Kooistra-Smid AM (2015) Assessing the public health risk of Shiga toxin-producing Escherichia coli by use of a rapid diagnostic screening algorithm. J Clin Microbiol 53:1588\u20131598. \n                    https:\/\/doi.org\/10.1128\/JCM.03590-14","journal-title":"J Clin Microbiol"},{"key":"4118_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1046\/j.1365-2672.1999.00695.x","volume":"86","author":"C Jenkins","year":"1999","unstructured":"Jenkins C, Chart H (1999) Serodiagnosis of infection with verocytotoxin-producing Escherichia coli. J Appl Microbiol 86:569\u2013575","journal-title":"J Appl Microbiol"},{"key":"4118_CR6","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00467-016-3420-7","volume":"31","author":"KL Wijnsma","year":"2016","unstructured":"Wijnsma KL, van Bommel SA, van der Velden T, Volokhina E, Schreuder MF, van den Heuvel LP, van de Kar NC (2016) Fecal diagnostics in combination with serology: best test to establish STEC-HUS. Pediatr Nephrol 31:2163\u20132170. \n                    https:\/\/doi.org\/10.1007\/s00467-016-3420-7","journal-title":"Pediatr Nephrol"},{"key":"4118_CR7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1046\/j.1365-2672.1999.00766.x","volume":"86","author":"H Chart","year":"1999","unstructured":"Chart H, Jenkins C (1999) The serodiagnosis of infections caused by Verocytotoxin-producing Escherichia coli. J Appl Microbiol 86:731\u2013740","journal-title":"J Appl Microbiol"},{"key":"4118_CR8","doi-asserted-by":"publisher","first-page":"e0182452","DOI":"10.1371\/journal.pone.0182452","volume":"12","author":"DS Castillo","year":"2017","unstructured":"Castillo DS, Rey Serantes DA, Melli LJ, Ciocchini AE, Ugalde JE, Comerci DJ, Cassola A (2017) A recombinant O-polysaccharide-protein conjugate approach to develop highly specific monoclonal antibodies to Shiga toxin-producing Escherichia coli O157 and O145 serogroups. PLoS One 12:e0182452. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0182452","journal-title":"PLoS One"},{"key":"4118_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1365-3083.2006.01848.x","volume":"64","author":"LB Zapata-Quintanilla","year":"2006","unstructured":"Zapata-Quintanilla LB, Palmeira P, Tino-De-Franco M, Amaral JA, Carbonare CB, Carbonare SB (2006) Systemic antibody response to diarrheagenic Escherichia coli and LPS O111, O157 and O55 in healthy Brazilian adults. Scand J Immunol 64:661\u2013667. \n                    https:\/\/doi.org\/10.1111\/j.1365-3083.2006.01848.x","journal-title":"Scand J Immunol"},{"key":"4118_CR10","doi-asserted-by":"publisher","first-page":"e0139803","DOI":"10.1371\/journal.pone.0139803","volume":"10","author":"TS Desin","year":"2015","unstructured":"Desin TS, Townsend HG, Potter AA (2015) Antibodies directed against Shiga-toxin producing Escherichia coli serotype O103 type III secreted proteins block adherence of heterologous STEC serotypes to HEp-2 cells. PLoS One 10:e0139803. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0139803","journal-title":"PLoS One"},{"key":"4118_CR11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1128\/JCM.02262-14","volume":"53","author":"LJ Melli","year":"2015","unstructured":"Melli LJ, Ciocchini AE, Caillava AJ, Vozza N, Chinen I, Rivas M, Feldman MF, Ugalde JE, Comerci DJ (2015) Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of Shiga toxin-producing-Escherichia coli-associated hemolytic-uremic syndrome. J Clin Microbiol 53:528\u2013538. \n                    https:\/\/doi.org\/10.1128\/JCM.02262-14","journal-title":"J Clin Microbiol"},{"key":"4118_CR12","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00467-016-3369-6","volume":"31","author":"P Bajracharya","year":"2016","unstructured":"Bajracharya P, Jain A, Baracco R, Mattoo TK, Kapur G (2016) Atypical hemolytic uremic syndrome: a clinical conundrum. Pediatr Nephrol 31:1615\u20131624. \n                    https:\/\/doi.org\/10.1007\/s00467-016-3369-6","journal-title":"Pediatr Nephrol"},{"key":"4118_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/joim.12546","volume":"281","author":"D Karpman","year":"2017","unstructured":"Karpman D, Loos S, Tati R, Arvidsson I (2017) Haemolytic uraemic syndrome. J Intern Med 281:123\u2013148. \n                    https:\/\/doi.org\/10.1111\/joim.12546","journal-title":"J Intern Med"},{"key":"4118_CR14","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","volume":"390","author":"F Fakhouri","year":"2017","unstructured":"Fakhouri F, Zuber J, Fremeaux-Bacchi V, Loirat C (2017) Haemolytic uraemic syndrome. Lancet 390:681\u2013696. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)30062-4","journal-title":"Lancet"},{"key":"4118_CR15","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nurnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368:2169\u20132181. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1208981","journal-title":"N Engl J Med"},{"key":"4118_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629\u2013637. \n                    https:\/\/doi.org\/10.1681\/ASN.2008030287","journal-title":"J Am Soc Nephrol"},{"key":"4118_CR17","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1097\/PCC.0b013e3182745675","volume":"14","author":"YA Soler","year":"2013","unstructured":"Soler YA, Nieves-Plaza M, Prieto M, Garcia-De Jesus R, Suarez-Rivera M (2013) Pediatric risk, injury, failure, loss, end-stage renal disease score identifies acute kidney injury and predicts mortality in critically ill children: a prospective study. Pediatr Crit Care Med 14:e189\u2013e195. \n                    https:\/\/doi.org\/10.1097\/PCC.0b013e3182745675","journal-title":"Pediatr Crit Care Med"},{"key":"4118_CR18","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0140-6736(91)90801-U","volume":"337","author":"H Chart","year":"1991","unstructured":"Chart H, Smith HR, Scotland SM, Rowe B, Milford DV, Taylor CM (1991) Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome. Lancet 337:138\u2013140","journal-title":"Lancet"},{"key":"4118_CR19","doi-asserted-by":"publisher","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM, Subcommittee on screening management of high blood pressure in children (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. \n                    https:\/\/doi.org\/10.1542\/peds.2017-1904","DOI":"10.1542\/peds.2017-1904"},{"key":"4118_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1086\/341781","volume":"186","author":"K Ludwig","year":"2002","unstructured":"Ludwig K, Bitzan M, Bobrowski C, Muller-Wiefel DE (2002) Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome. J Infect Dis 186:566\u2013569. \n                    https:\/\/doi.org\/10.1086\/341781","journal-title":"J Infect Dis"},{"key":"4118_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1099\/0022-1317-51-6-522","volume":"51","author":"H Chart","year":"2002","unstructured":"Chart H, Perry NT, Cheasty T, Wright PA (2002) The kinetics of antibody production to antigens of Escherichia coli O157 in a pregnant woman with haemolytic uraemic syndrome. J Med Microbiol 51:522\u2013525. \n                    https:\/\/doi.org\/10.1099\/0022-1317-51-6-522","journal-title":"J Med Microbiol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-4118-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4118-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4118-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T21:07:05Z","timestamp":1572037625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-4118-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4118"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-4118-9","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,26]]},"assertion":[{"value":"1 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The local ethics committee approved this study (2017-3490).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. J.E. Ugalde and Dr. D.J. Comerci are responsible for the production and distribution of the glycoproteins used in the assay. A patent has been filed regarding the application of recombinant glycoproteins for diagnostics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}